Episode
J&J Aims to Cure or Control Cancer in 10 Years
- Published
- Jun 16, 2026
- Duration seconds
- 113
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/j-j-aims-to-cure-or-control-cancer-in-10-years/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/j-j-aims-to-cure-or-control-cancer-in-10-years.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
J&J’s CEO Joaquin Duato unveiled a bold 10-year plan to either cure or manage certain cancers like chronic diseases, aiming for oncology dominance by 2030. Fueling this mission, J&J is leveraging AI to turbocharge drug development and just acquired Firefly Bio for $1 billion to gain its revolutionary Firelink platform—targeting deadly KRAS-mutated tumors with precision therapy that could slash patient suffering and expand their pipeline dramatically. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/2525b7794165c8b9